1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:ADCs of tumors versus degree of small foci of necrosis in pathologic specimens
Lesion ADC (×10−3 mm2/second) No Necrosis Mild Necrosis Conspicuous Necrosis SCC (n = 35) 0.93 ± 0.06 (n = 13) 0.96 ± 0.12 (n = 19) 1.01 ± 0.09 (n = 3) Lymphoma (n = 9) 0.63 ± 0.10 (n = 4) 0.73 ± 0.05 (n = 5) Not applicable
Note.—ADC values did not significantly differ according to degree of small foci of necrosis. Data are the mean ± standard deviation.